A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.

Clinical trial NCT04882514 · COMPLETED

Trial details

NCT number: NCT04882514
Sponsor: University of Alberta
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Group A Streptococcal Infection

Start date: 2022-11-07
Primary completion: 2025-05-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.